Virtual Event: Democrats’ Last Chance for Drug Pricing Reform?

Editor’s note: A recording of the event is embedded below.

Once again Congress is barreling towards drug pricing reform. STAT will sit down with key decision-makers to talk about the latest developments from Capitol Hill and the White House.

Agenda:

Introduction:

• Brent Dover, CEO, Kalderos (sponsor speaker)

Part 1: Listening to the Experts

• Rena Conti, Ph.D., associate professor, Department of Markets, Public Policy and Law, Questrom School of Business, Boston University
• Stacie B. Dusetzina, Ph.D., associate professor of health policy, Ingram associate professor of cancer research, Vanderbilt University School of Medicine
• Richard G. Frank, Ph.D., director of the USC-Brookings Schaeffer Initiative on Health Policy; fellow in economic studies; Margaret T. Morris professor of health economics, emeritus, department of health care policy, Harvard Medical School
• Rachel Cohrs, Washington correspondent, STAT (moderator)

Part 2: A Top Senator’s View

• Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee
• Rachel Cohrs, Washington correspondent, STAT (moderator)